GlassScriptPhysician profile
Alan R Pope
NPI 1730160391
$1,168.08
in general payments reported to CMS, 2019-2025
16 companies · $505 in 2025
The $505 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2020: $98.66 · 2021: $12.91 · 2022: $270 · 2023: $108 · 2024: $18.77 · 2025: $505.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $632.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $632.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $476.21 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Inari Medical, INC. | $188.90 | 2022 | |
| Inspire Medical Systems, INC. | $115.11 | 2025 | Inspire |
| Grifols USA, LLC | $68.40 | 2025 | Prolastin-C Liquid |
| Philips North America LLC | $63.22 | 2019-2025 | Patient Interface Software |
| Insmed, INC. | $56.88 | 2020-2022 | |
| Edwards Lifesciences Corporation | $49.42 | 2019 | |
| Advanced Respiratory, INC | $20.85 | 2020 | |
| Baxter Healthcare | $20.00 | 2025 | |
| Verona Pharma, INC. | $19.23 | 2025 | Ohtuvayre |
| Genentech USA, INC. | $18.70 | 2019 | |
| Novo Nordisk INC | $15.89 | 2025 | Wegovy |
| Amgen INC. | $14.90 | 2023 | Tezspire |
| Teva Pharmaceuticals USA, INC. | $14.48 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $12.98 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $12.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Pope listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.